1,25(OH) 2 D 3 treatment significantly protected mice from development of EAE.

Li Bo; J. Baylink David; Deb Chandra; Zannetti Claudia; Rajaallah Fatima; Xing Weirong; H. Walter Michael; William Lau K.-H.; Qin Xuezhong; David J. Baylink

doi:10.1371/JOURNAL.PONE.0058808.G001

1,25(OH) 2 D 3 treatment significantly protected mice from development of EAE.

Li Bo, J. Baylink David, Deb Chandra, Zannetti Claudia, Rajaallah Fatima, Xing Weirong, H. Walter Michael, William Lau K.-H., Qin Xuezhong, David J. Baylink

Research output: Non-textual form › Digital or Visual Products

Original language	American English
Media of output	Online
DOIs	https://doi.org/10.1371/JOURNAL.PONE.0058808.G001
State	Published - Mar 15 2013

Disciplines

Internal Medicine
Endocrinology

Access to Document

10.1371/JOURNAL.PONE.0058808.G001License: Unspecified

OpenUrl availability

Full text

Cite this

@misc{babdb70c545f4f27a45538132bedbcfa,

title = "1,25(OH) 2 D 3 treatment significantly protected mice from development of EAE.",

author = "Li Bo and David, {J. Baylink} and Deb Chandra and Zannetti Claudia and Rajaallah Fatima and Xing Weirong and Michael, {H. Walter} and K.-H., {William Lau} and Qin Xuezhong and Baylink, {David J.}",

note = "EAE was induced by immunonization with MOG (Material Methods). Mice were injected i.p. with 2 µg of 1,25(OH)2D3 one day before MOG injection and then 0.1 µg 1,25(OH)2D3 every other day till day 14 post-MOG injection. Body weight (A) and clinical score (B) were determined at day 14 post-MOG injection.",

year = "2013",

month = mar,

day = "15",

doi = "10.1371/JOURNAL.PONE.0058808.G001",

language = "American English",

}

TY - ADVS

T1 - 1,25(OH) 2 D 3 treatment significantly protected mice from development of EAE.

AU - Bo, Li

AU - David, J. Baylink

AU - Chandra, Deb

AU - Claudia, Zannetti

AU - Fatima, Rajaallah

AU - Weirong, Xing

AU - Michael, H. Walter

AU - K.-H., William Lau

AU - Xuezhong, Qin

AU - Baylink, David J.

N1 - EAE was induced by immunonization with MOG (Material Methods). Mice were injected i.p. with 2 µg of 1,25(OH)2D3 one day before MOG injection and then 0.1 µg 1,25(OH)2D3 every other day till day 14 post-MOG injection. Body weight (A) and clinical score (B) were determined at day 14 post-MOG injection.

PY - 2013/3/15

Y1 - 2013/3/15

UR - http://figshare.com/articles/_1_25_OH_2_D_3_treatment_significantly_protected_mice_from_development_of_EAE_/652827

U2 - 10.1371/JOURNAL.PONE.0058808.G001

DO - 10.1371/JOURNAL.PONE.0058808.G001

M3 - Digital or Visual Products

ER -

1,25(OH) 2 D 3 treatment significantly protected mice from development of EAE.

Disciplines

Access to Document

OpenUrl availability

Other files and links

Cite this